Neurocrine Biosciences (NASDAQ:NBIX) Price Target Cut to $140.00 by Analysts at Truist Financial



Truist Financial lowered their target price on Neurocrine Biosciences from $169.00 to $140.00 and set a “buy” rating on the stock in a research note on Tuesday.



Source link

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *